Public Health Today—April 24, 2026
This weekly Public Health update highlights key developments across policy,…
Lucid Diligence Brief: MeiraGTx re-acquires bota-vec rights from J&J
Lucid Diligence Brief: MeiraGTx re-acquires bota-vec rights from J&J…
Neuroscience Today—April 15, 2026
This week’s Neuroscience update highlights regulatory progress, biomarker-based…
Public Health Today—April 3, 2026
This weekly update in public health highlights new evidence across…
Public Health Video Recap—March 13, 2026
Welcome to our biweekly public health video recap, summarizing the latest…
Public Health Today—March 6, 2026
This weekly Public Health update highlights recent research findings,…
Cell and Gene Therapy Today—March 5, 2026
This is a weekly update in gene and cell therapy, covering key regulatory…
Neuroscience Today—March 4, 2026
This week's Neuroscience update covers key developments across late-stage…
Lucid Diligence Brief: Candel Therapeutics $100m funding for CAN-2409 in localized prostate cancer
Lucid Diligence Brief: Candel Therapeutics $100m funding for CAN-2409 in…
Cell and Gene Therapy Today—February 19, 2026
This week's update in gene and cell therapy covers notable developments…
Rare Diseases Today—February 12, 2026
This week's Rare diseases update covers regulatory actions, clinical…
Lucid Diligence Brief: Eli Lilly Pipeline Rationalization
Lucid Diligence Brief: Eli Lilly Pipeline Rationalization Professional…